We previously demonstrated ABE-mediated correction of nonsense mutations in COL7A1 that cause recessive dystrophic epidermolysis bullosa (RDEB) in primary human patient-derived fibroblasts (Osborn et al., 2020). The gene discussed is COL7A1; the disease is recessive dystrophic epidermolysis bullosa.